N

Neuroplast

29 employees

Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.

Basic info

Industry

biotechnology research

Sectors

Traumatic brain injury
Parkinson's disease
Neuro-Cells (r)
Neurodegenerative diseases
Regenerative medicine
MS
Stem cell technology
ALS
GMP - Good Manufacturing Practice
Spinal cord injury
Fast-track development programs
Orphan diseases
Therapeutics
Alternative Medicine
Frontotemporal dementia
Living medicine

Date founded

2014

Funding rounds raised

Total raised

$11M

from 4 investors over 4 rounds

N

Neuroplast raised $11M on November 17, 2021

Investors: Brightlands Venture Partners and NV Industriebank LIOF

N

Neuroplast raised $4.3M on February 19, 2020

Investors: Brightlands Venture Partners and NV Industriebank LIOF

FAQ